LIGAND PHARMACEUTICALS INC — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2012-06-29

Reporting Person: FOEHR MATTHEW W (EVP and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-29	Common Stock	J	1250.0	$10.1235	Acquired	37500.0	Direct

Footnotes

F1: Shares Acquired under Ligand's employee stock purchase plan.